| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |